Delek US Holdings, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DK research report →
Range $65 – $97
Price Chart
About the company
Delek US Holdings, Inc. is an integrated downstream energy corporation operating within the United States. Its operations are divided into three core segments: Refining, Logistics, and Retail.
- CEO
- Avigal Soreq
- IPO
- 2006
- Employees
- 1,902
- HQ
- Brentwood, TN, US
Get TickerSpark's AI analysis on DK
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $3.62B
- P/E
- 3.15
- Fwd P/E
- 2.66
- PEG
- -0.00
- P/S
- 0.27
- P/B
- 2.84
- EV/EBITDA
- 2.57
- Div Yield
- 1.75%
- Gross Margin
- 15.58%
- Op Margin
- 14.11%
- Net Margin
- 8.70%
- ROE
- 228.60%
- ROIC
- 26.24%
Latest fiscal year · YoY change
- Revenue
- $10.72B-9.5%
- Gross Profit
- $568.30M+937.0%
- Op Income
- $395.90M
- Net Income
- $-22,800,000+95.9%
- EPS
- $-0.38+95.7%
- OCF Growth
- +925.6%
- FCF Growth
- +104.4%
- 52W High
- $82.27
- 52W Low
- $25.85
- 50D MA
- $72.21
- 200D MA
- $55.58
- Beta
- 0.56
- RSI (14)
- 35
- Avg Volume
- 1.99M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Delek US said Q3 was a “landmark quarter,” with very strong adjusted earnings and cash flow, higher EOP targets, a bigger dividend, and more buybacks supported by SRE monetization and better refining performance.· November 6, 2026
- Q3 adjusted EBITDA was approximately $1.28 billion and adjusted EPS was $13.55; excluding the 50% RVO adjustment and SRE impacts, adjusted EBITDA was approximately $1.04 billion and adjusted EPS was approximately $10.53.
- Cash flow from operations was $567 million, or about $1.38 billion excluding working capital, helped by expected SRE proceeds of approximately $425 million in Q4.
- Management raised its EOP target to at least $250 million on an annual run-rate basis and said about $60 million of EOP contribution hit the P&L in Q3.
- The board increased the quarterly dividend by approximately 18% to $0.30 per share and the company expects about $100 million of share buybacks between now and year-end.
- DKL raised 2026 EBITDA guidance to $530 million to $560 million and expects an additional $60 million of EBITDA in 2027 from organic projects on a run-rate basis.
Delek reported Q3 net income of approximately $1.13 billion, or $18.22 per share, with EBITDA of approximately $1.64 billion. On an adjusted basis, net income was approximately $843 million, or $13.55 per share, with adjusted EBITDA of approximately $1.28 billion. Excluding the 50% RVO adjustment and the impact of SREs granted during the quarter, adjusted EBITDA was approximately $1.04 billion and adjusted EPS was approximately $10.53 per share. Cash flow from operations was $567 million, with $111 million of capex, including $55 million at DKL. For Q4, throughput guidance is 288,000 to 308,000 barrels per day, with operating expenses of $225 million to $235 million, G&A of $50 million to $55 million, D&A of $115 million to $125 million, and total net interest expense of $52 million to $67 million. DKL raised 2026 EBITDA guidance to $530 million to $560 million. Management said the company expects approximately $425 million of SRE proceeds in Q4 and expects to spend about $100 million on buybacks in Q4.
Avigal Soreq framed the quarter as evidence that Delek’s transformation is working, citing stronger operations, better reliability, and a more powerful free-cash-flow profile. He repeatedly emphasized discipline in capital allocation, saying the company will keep balancing dividends, buybacks, and balance sheet improvement rather than hold excess cash. His tone was confident and upbeat, especially on the company’s ability to benefit from inland crude access, higher distillate yield, and quick response to market changes.
Robert Wright focused on the hard numbers: $1.13 billion of net income, $1.64 billion of EBITDA, $567 million of operating cash flow, and $111 million of capex. He explained that the working-capital outflow included about $425 million tied to SRE receivables that management expects to receive in Q4, plus roughly $200 million of timing items and about $160 million of other financing-related items. He also laid out Q4 guidance for throughput, Opex, G&A, D&A, and interest expense, and noted that stand-alone DK net debt improved by $224 million versus Q2 to a net cash position of approximately $22 million.
Analysts pressed on RIN/SRE exposure, asking whether Delek was current on its obligations and how much of the $425 million SRE monetization would still leave the company short. Management said the company stays in compliance and is proactively managing its position, but declined to give a detailed RIN-buying strategy or specific remaining RIN length. On capital allocation, management said it does not want to hold excess cash and prefers to return capital through dividends and buybacks; it also said there is no material CapEx tied to reported Defense Production Act support and that Tyler will stay at 75,000 barrels per day of crude. Questions on DKL ownership, turnarounds, and 2027 buybacks were met with a mostly wait-and-see stance, with management saying it is still “putting our ducks in a row” for 2027.
The call suggested Delek is generating materially stronger cash flow and is using it to de-risk the balance sheet while returning capital to shareholders. Management also sounded confident that EOP, improved capture rates, and SRE monetization can support further earnings and cash flow gains, with DKL’s growth projects and higher EBITDA guidance adding another source of upside.
A key risk is that the company’s results and cash flow are still exposed to volatile refining margins, freight rates, and RIN/SRE policy outcomes, all of which management discussed at length. Analysts also highlighted uncertainty around the actual RIN length and future compliance needs, while management was unwilling to quantify that position in detail. There is also execution risk in 2027 around buybacks, turnarounds, and whether current strong economics persist if margins normalize.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 98.0%
- Shares Outstanding
- 60.61M
- Float Shares
- 59.40M
of shares held by institutions
312 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for DK, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Van TaylorHouse · TX03 | Sell | Mar 25, 19 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 10.24M | ▲ 4.83M |
| Vanguard Group Inc | 6.33M | ▲ 38.58K |
| Vanguard Portfolio Management LLC | 5.05M | ▲ 1.17M |
| State Street Corp | 3.87M | ▲ 651.54K |
| Vanguard Capital Management LLC | 2.75M | ▲ 88.94K |
| Rubric Capital Management LP | 2.69M | 0 |
| Two Sigma Investments, LP | 1.86M | ▼ 317.75K |
| Allianz Asset Management Gmbh | 1.85M | ▼ 56.01K |
| Geode Capital Management, LLC | 1.71M | ▲ 168.94K |
| Morgan Stanley | 1.64M | ▲ 503.83K |
| Fmr LLC | 1.47M | ▼ 552.76K |
| Norges Bank | 1.42M | ▲ 1.42M |
Held by 389 ETFs
Biggest fund positions in DK by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 11, 26 | Russell Amber | sell | 5,392 |
| Sep 11, 26 | FINNERTY WILLIAM J | sell | 1,341 |
| Sep 11, 26 | FINNERTY WILLIAM J | sell | 1,602 |
| Sep 10, 26 | Spiegel Reuven | other | 969 |
| Sep 10, 26 | Soreq Avigal | other | 5,626 |
| Sep 10, 26 | Wright Robert G. | other | 311 |
| Sep 10, 26 | Russell Amber | other | 1,736 |
| Sep 10, 26 | Hobbs Mark Wayne | other | 1,227 |
| Sep 4, 26 | Sutil Vicky | sell | 6,397 |
| Sep 1, 26 | Spiegel Reuven | sell | 7,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our DK coverage
Recent articles, reports, and earnings notes.
Want a deeper read on DK?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
55,323 Shares in Delek US Holdings, Inc. $DK Bought by Edgestream Partners L.P.
defenseworld.net · Nov 20
5 Stocks Adored by Brokers to Buy Amid the Current Turbulence
zacks.com · Nov 17
Delek US Holdings, Inc. $DK Position Decreased by Alberta Investment Management Corp
defenseworld.net · Nov 17
DK vs. DINO: Which Refining Stock Has the Edge After Q3 Earnings?
zacks.com · Nov 16
Buy, Sell, or Hold? Wednesday’s Top Upgrades and Downgrades: Akamai Technologies, Apple, BILL Holdings, Corning, Form Factor, Guidewire Software, NVIDIA, Riot Platforms, Toast, and More
247wallst.com · Nov 11
3 Oil Stocks to Buy on the Dip After Crushing Q3 Expectations: CVI, DK, NOG
zacks.com · Nov 10
Delek US Holdings Is Intriguing, But Not Compelling
seekingalpha.com · Nov 10
Calamos Advisors LLC Makes New $1.20 Million Investment in Delek US Holdings, Inc. $DK
defenseworld.net · Nov 10
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
